Tekturna and Premarin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tekturna (aliskiren hemifumarate) and Premarin (estrogens, conjugated). Common drug interactions include diarrhoea among females and chest discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Tekturna and Premarin. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Premarin?

Premarin has active ingredients of estrogens, conjugated. It is often used in hormone replacement therapy. eHealthMe is studying from 99,630 Premarin users. Check the latest studies of Premarin.



On Jul, 23, 2026

42 people who take Tekturna and Premarin together, and have interactions are studied.

Tekturna and Premarin drug interactions.

What are the common drug interactions of Tekturna and Premarin, by gender? *:

female:

  1. Diarrhoea
  2. Drug effect decreased
  3. Drug ineffective
  4. Glossodynia (a burning or painful sensation in the tongue)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Oedema (fluid collection in tissue)
  7. Pain
  8. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  9. Pyrexia (fever)
  10. Renal failure (kidney dysfunction)

male:

  1. Chest discomfort
  2. Flushing (the warm, red condition of human skin)

What are the common drug interactions of Tekturna and Premarin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Injection site pruritus (severe itching at injection site)
  2. Injection site rash

50-59:

  1. Nephrogenic anaemia (anaemia due to kidney disease)
  2. Oedema (fluid collection in tissue)
  3. Pain
  4. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)
  7. Swollen tongue (swelling of tongue)
  8. Tongue oedema (swelling of tongue)
  9. Drug ineffective
  10. Addison's disease (addison's disease, a hormonal disorder disease)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Dyspnoea (difficult or laboured respiration)
  3. Diarrhoea
  4. Dysarthria (speech disorder)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Lip oedema (swelling of lip)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Muscle spasms (muscle contraction)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 16.67%
  2. Sleep Disorder: 5 people, 11.90%
  3. High Blood Cholesterol: 5 people, 11.90%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 9.52%
  5. Osteoporosis (bones weak and more likely to break): 4 people, 9.52%
  6. Insomnia (sleeplessness): 4 people, 9.52%
  7. Pain: 3 people, 7.14%
  8. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 3 people, 7.14%
  9. Diabetes: 3 people, 7.14%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and Premarin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tekturna and Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tekturna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tekturna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Premarin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate and estrogens, conjugated (the active ingredients of Tekturna and Premarin, respectively), and Tekturna and Premarin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: